|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Canada |
First Approval Date31 Dec 1984 |
/ Not yet recruitingPhase 3IIT To evaluate the efficacy and safety of Mitoxantrone Hydrochloride Injection for Tracing as a lymphatic tracer in patients undergoing radical gastrectomy for gastric cancer: a multicenter, randomized, single-blind, positive parallel controlled superiority clinical trial
100 Clinical Results associated with Shenzhen China Resources Jiuchuang Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Shenzhen China Resources Jiuchuang Pharmaceutical Co., Ltd.
100 Deals associated with Shenzhen China Resources Jiuchuang Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Shenzhen China Resources Jiuchuang Pharmaceutical Co., Ltd.